Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 5;13(1):142.
doi: 10.3390/cancers13010142.

The Network of Cytokines in Brain Metastases

Affiliations
Review

The Network of Cytokines in Brain Metastases

Jawad Fares et al. Cancers (Basel). .

Abstract

Brain metastases are the most common of all intracranial tumors and a major cause of death in patients with cancer. Cytokines, including chemokines, interferons, interleukins, lymphokines, and tumor necrosis factors are key regulators in the formation of brain metastases. They regulate the infiltration of different cellular subsets into the tumor microenvironment and affect the therapeutic outcomes in patients. Elucidating the cancer cell-cytokine interactions in the setting of brain metastases is crucial for the development of more accurate diagnostics and efficacious therapies. In this review, we focus on cytokines that are found in the tumor microenvironment of brain metastases and elaborate on their trends of expression, regulation, and roles in cellular recruitment and tumorigenesis. We also explore how cytokines can alter the anti-tumor response in the context of brain metastases and discuss ways through which cytokine networks can be manipulated for diagnosis and treatment.

Keywords: brain metastasis; brain tumor; chemokines; cytokines; interferons; interleukins; lymphokines; tumor necrosis factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish.

Figures

Figure 1
Figure 1
Cytokine and chemokine levels in brain metastases. Identifying the different levels of cytokines and chemokines in brain metastases from different primary tumors allows for the differentiation between patients with and without brain metastases. Red-colored cytokines correspond to studies that are based on patient samples.

References

    1. Sokol C.L., Luster A.D. The chemokine system in innate immunity. Cold Spring Harb. Perspect. Biol. 2015;7:a016303. doi: 10.1101/cshperspect.a016303. - DOI - PMC - PubMed
    1. Ramesh G., MacLean A.G., Philipp M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediat. Inflamm. 2013;2013:480739. doi: 10.1155/2013/480739. - DOI - PMC - PubMed
    1. Fares J., Fares M.Y., Khachfe H.H., Salhab H.A., Fares Y. Molecular principles of metastasis: A hallmark of cancer revisited. Signal. Transduct. Target Ther. 2020;5:28. doi: 10.1038/s41392-020-0134-x. - DOI - PMC - PubMed
    1. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer. 2004;4:540–550. doi: 10.1038/nrc1388. - DOI - PubMed
    1. Fares J., Kanojia D., Rashidi A., Ulasov I., Lesniak M.S. Genes that Mediate Metastasis across the Blood-Brain Barrier. Trends Cancer. 2020;6:660–676. doi: 10.1016/j.trecan.2020.04.007. - DOI - PMC - PubMed